Search
healthcare › clinical-trials › h-37231
… A Randomized Trial of the Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants … dysplasia (BPD), and further data are needed to support its adoption as a standard care practice. The … group) will have a shorter length of initial hospital stay compared to infants receiving the standard regimen of an …
news › space-health-institute-seeks-to-safeguard-astronaut-health-through-control-of-metabolism-and-homeostasis
… therapies and engineering capabilities with the potential to protect health in deep space. TRISH seeks and funds … high-reward and creative solutions that can be used to protect astronauts on long duration exploration missions. … is seeking novel research and multi-disciplinary approaches to reduce health risks through manipulation of human …
healthcare › clinical-trials › h-48193
… A 27 Week Phase 3, Double-blind, Placebo-controlled Trial to evaluate Tavapadon for PD in Levodopa treatment adults with motor fluctuations. Open extension study to follow. … studies evaluating an oral investigational drug (tavapadon) to see if it may help improve PD symptoms that impact your …
news › drs-lemaire-and-shen-awarded-nih-nhlbi-r01-funding-to-study-aortic-degeneration
… surgery in the Division of Cardiothoracic Surgery and director of the Aortic Disease Research Lab , have been awarded … form of programmed cell death that can represent a common pathway to aortic SMC loss. The long-term goal of this study is … Drs. LeMaire and Shen Awarded NIH-NHLBI R01 Funding to Study Aortic Degeneration …
healthcare › clinical-trials › h-44783
… This study is enrolling eligible patients who present to Ben Taub and St Luke's Emergency Departments with a trauma. The purpose of this research is to evaluate the ability of blood biomarkers, clinical … neurocognitive testing and neuropsychological testing in combination to identify patients with mild traumatic brain …
news › baylor-and-rice-receive-2-3-million-to-develop-antibody-therapy-for-metastatic-breast-cancer
… Defense Congressionally Directed Medical Research Programs to develop a novel NanoGel antibody therapy that targets ER+ breast cancer that has metastasized to bone. “Current treatments work well for ER+ breast … a McNair Scholar at Baylor and a member of the Dan L Duncan Comprehensive Cancer Center. To address this problem, the …
news › fda-grants-orphan-drug-designation-to-potential-treatment-of-stxbp1-developmental-and-epileptic-encephalopathy
… Baylor College of Medicine and Texas Children’s Hospital doctors have led to the U.S. Food and Drug Administration (FDA) granting … Swati Tole, M.D., Chief Medical Officer at Capsida. “We are committed to advancing CAP-002, with our IND filing in the … FDA Grants Orphan Drug Designation to Potential Treatment of STXBP1 Developmental and Epileptic …
news › integrative-exome-sequencing-and-machine-learning-identify-new-genes-contributing-to-systemic-sclerosis-risk
… Systemic sclerosis (SSc) is a severe autoimmune disease with complex genetic causes. Some genetic contributors have been identified, but others remain unknown, which … exome sequencing and evolutionary action machine learning to identify protein changes and their associated mechanisms …
news › brain-stars-hold-the-power-to-preserve-cognitive-function-in-model-of-alzheimers-disease
… cells known as astrocytes, star shaped cells in the brain, to remove the toxic amyloid plaques that build up in many Alzheimer’s … for normal brain function, including facilitating brain communications and memory storage. As the brain ages, … Brain “stars” hold the power to preserve cognitive function in model of Alzheimer’s …
news › understanding-the-path-from-genetic-changes-to-parkinsons-disease-opens-possibilities-for-early-diagnosis
… the possibility of identifying people at risk before symptoms appear and developing strategies to treat the disease rather than manage the symptoms. “Parkinson’s disease is the second most common neurodegenerative disease after Alzheimer's disease, … Understanding the path from genetic changes to Parkinson’s disease opens possibilities for early …